Sravan Emany
Former Senior Vice President, Chief Operating Officer and Chief Financial OfficeratIronwood Pharmaceuticals· In proxies 2021–2024
Pay in FY2024Ironwood Pharmaceuticals stock -61.3% the same year
Sravan Emany was paid $3.0M in FY2024 (Dec). Ironwood Pharmaceuticals stock fell 61.3% that year.
Pay$100 in the stock at the end of FY20 → $42
Experience
- Ironwood PharmaceuticalsPublic company · 5 yr
- Former Senior Vice President, Chief Operating Officer and Chief Financial Officer2021 – Present · 5 yrStock in role -69%
Roles come from the proxy statements of each company.
Activity
Two people shown as one, or a wrong number?